An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 213721
Company: BLUEPRINT MEDICINES

Products on NDA 213721

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
GAVRETO	PRALSETINIB	100MG	CAPSULE;ORAL	Prescription	None	Yes	Yes

Approval Date(s) and History, Letters, Labels, Reviews for NDA 213721

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
09/04/2020	ORIG-1	Approval	Type 1 - New Molecular Entity	PRIORITY; Orphan	Review	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/nda/2020/213721Orig1s000TOC.cfm

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
03/22/2024	SUPPL-15	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/213721s015lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/213721Orig1s015ltr.pdf
07/20/2023	SUPPL-14	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213721s014lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/213721Orig1s014ltr.pdf
06/30/2023	SUPPL-11	Labeling-Package Insert, Labeling-Patient Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213721s011lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/213721Orig1s011ltr.pdf
08/09/2023	SUPPL-9	Efficacy-Labeling Change With Clinical Data	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213721s009lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/213721Orig1s009ltr.pdf
09/28/2022	SUPPL-7	Labeling-Container/Carton Labels, Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213721s007lbl.pdf
02/02/2022	SUPPL-5	Labeling-Container/Carton Labels	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213721s005lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/213721Orig1s005ltr.pdf
11/10/2021	SUPPL-4	Labeling-Container/Carton Labels, Labeling-Package Insert, Labeling-Patient Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213721s004lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/213721Orig1s004ltr.pdf
09/04/2020	SUPPL-1		Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213721s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/213721Orig1s000ltr.pdf

Labels for NDA 213721

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
03/22/2024	SUPPL-15	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/213721s015lbl.pdf
08/09/2023	SUPPL-9	Efficacy-Labeling Change With Clinical Data	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213721s009lbl.pdf
07/20/2023	SUPPL-14	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213721s014lbl.pdf
06/30/2023	SUPPL-11	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213721s011lbl.pdf
06/30/2023	SUPPL-11	Labeling-Patient Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213721s011lbl.pdf
09/28/2022	SUPPL-7	Labeling-Container/Carton Labels	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213721s007lbl.pdf
09/28/2022	SUPPL-7	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213721s007lbl.pdf
02/02/2022	SUPPL-5	Labeling-Container/Carton Labels	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213721s005lbl.pdf
11/10/2021	SUPPL-4	Labeling-Container/Carton Labels	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213721s004lbl.pdf
11/10/2021	SUPPL-4	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213721s004lbl.pdf
11/10/2021	SUPPL-4	Labeling-Patient Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213721s004lbl.pdf
09/04/2020	SUPPL-1	Type 1 - New Molecular Entity	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213721s000lbl.pdf

Top